Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
| Autor: | Chen, I-Chun, Hu, Fu-Chang, Lin, Ching-Hung, Huang, Shu-Min, Chang, Dwan-Ying, Cheng, Ann-Lii, Lu, Yen-Shen |
|---|---|
| Zdroj: | In The Breast October 2021 59:211-220 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect